We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Barr Deal May Usher in First Follow-On Biologic
Barr Deal May Usher in First Follow-On Biologic
April 8, 2005
Generic firm Barr Laboratories is taking the plunge into the follow-on biologics market, announcing recently that it is partnering with Croatian biopharmaceutical firm PLIVA to develop its first biogeneric product.